Crohn Disease Clinical Trial
Official title:
Evaluation of Anorectal Function in Perianal Crohn's Disease: a Pilot Study.
Verified date | February 2020 |
Source | The Leeds Teaching Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Perianal Crohn's disease is a disabling disease associated with increased morbidity and
impaired quality of life. It is associated with pain, discharge, fecal incontinence and
sexual and psychological impairment. In refractory cases, a stoma may be necessary. A higher
prevalence is seen with increasing Crohn's disease duration and appears to vary according to
the disease location. The presence of symptoms associated with anorectal dysfunction, such as
fecal incontinence, can sometimes poorly correlate with the presence of anal sphincter
abnormalities. Moreover, even in patients without symptoms, the presence of anal sphincter
abnormalities may have important implications for the future selection of type of delivery,
and might even pose a contra-indication for certain types of anorectal surgeries.
Studies evaluating possible chronic complications of perianal Crohn's disease on anorectal
function are lacking. There is a need for a better understanding of the chronic complications
of this disease, and the role of high-resolution anorectal manometry in diagnosing these
abnormalities during follow-up of these patients. This study will evaluate the chronic
repercussions of perianal Crohn's disease in patients with a previous anal fistula and/or
abscess that has healed and/or is inactive.
Status | Completed |
Enrollment | 16 |
Est. completion date | February 22, 2020 |
Est. primary completion date | February 22, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. = 18 and = 75 year-old patients 2. CD in clinical remission, defined by a Harvey-Bradshaw index <5 3. Perianal CD history, defined by the presence of a perianal fistula and/or abscess that were treated/heal/inactive 4. Perianal Disease Activity Index (PDAI) of =4 5. Asymptomatic or symptomatic patients (anorectal symptoms) will be included, as long they fulfill the other inclusion criteria, like for anorectal symptomatic patients having a PDAI=4 6. Endoanal ultrasound without an image compatible with new/non-treated abscess or perianal fistula 7. Both previous simple or complex perianal fistula (according to the American College of Gastroenterology) will be considered. Exclusion Criteria: 1. Women with previous vaginal delivery 2. Ileostomy 3. Previous anorectal surgery as hemorrhoidectomy or lateral sphincterotomy 4. Active rectal disease. No rectal involvement will be defined by no previous rectal involvement ever described or if previous involvement, endoscopy within 18 months showing no current involvement 5. Previous or current anal fissure 6. Anal stricture 7. Current or previous rectovaginal fistula (previous/last pelvic MRI). A previous seton placement, abscess drainage, fistulotomy and lay open fistula are not an exclusion criteria. Patients with a current seton can only be included if the seton was place more than 24 weeks ago, and the endoanal ultrasound does not show any new/non-treated perianal fistula/abscess. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Leeds Teaching Hospital NHS Trust | Leeds |
Lead Sponsor | Collaborator |
---|---|
The Leeds Teaching Hospitals NHS Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Wexner score (fecal incontinence score). | 5 items score, including solid, liquid, gas incontinence, wearing pads and lifestyle alterations, scored from 0 (normal) to 4 (more severe). | 5 minutes | |
Primary | Resting pressure, squeezing pressure, anorectal pressure changes during cough, anorectal pressure changes during simulated defecation, presence of a rectoanal inhibitory reflex and assessment of rectal sensitivity to distension. | Evaluated by high-resolution anorectal manometry. | 30 minutes | |
Primary | Anal sphincters integrity. | Evaluated by endoanal ultrasound. | 5 minutes | |
Primary | Ballon expulsion test duration. | 3 minutes | ||
Secondary | Presence of symptoms suggesting obstructed defection. | Prolonged and unsuccessful straining at stool, self-digitation for defecation, sense of incomplete evacuation or sensation of anorectal obstruction/blockage and a stool frequency of less than three times per week. | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Recruiting |
NCT05169593 -
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
|
Phase 4 | |
Recruiting |
NCT06116604 -
Early Bowel Resection for Terminal Ileal Crohn's Disease
|
||
Recruiting |
NCT05627128 -
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
|
N/A | |
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Recruiting |
NCT05294107 -
Intestinal Organoids
|
N/A | |
Withdrawn |
NCT04349449 -
ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
|
||
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Completed |
NCT03058679 -
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
|
N/A | |
Completed |
NCT02871635 -
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
|
Phase 3 | |
Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
Recruiting |
NCT03913572 -
Treatment of Perianal Disease Using Adipose-derived Stem Cells
|
||
Completed |
NCT03606499 -
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
|
||
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Terminated |
NCT04102111 -
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
|
Phase 2 | |
Recruiting |
NCT04997733 -
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
|
Phase 3 | |
Recruiting |
NCT05906576 -
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
|
Phase 4 | |
Not yet recruiting |
NCT04502303 -
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
|
Phase 2 | |
Not yet recruiting |
NCT04398836 -
Preoperative Nutrition for Crohn's Disease Patients
|
Phase 3 |